Big strides in children's healthcare as USask's Dr. Tyler Wenzel is awarded for rethinking treatments for rare pediatric ...
A seven-year Dutch study shows that a single baseline blood measurement of neurofilament light chain predicts the pace of ...
Study to Explore Oral Maintenance Dosing Regimens Following Initial Weight Loss with Subcutaneous VK2735. Monthly and Every-Other-Week Subcutaneous Regimens to also be Evaluated.
Helen explains how the NSF QP Alumni community helps Qualified Persons stay current through regulatory updates, peer discussions and shared experience, offering practical insight into evolving industr ...
Neuraxpharm and Minoryx have announced that the European Commission has granted marketing authorisation under exceptional ...
Detailed price information for Presurance Holdings Inc (PRHI-Q) from The Globe and Mail including charting and trades.
Study to Explore Oral Maintenance Dosing Regimens Following Initial Weight Loss with Subcutaneous VK2735 Monthly and Every-Other-Week Subcutaneous Regimens to also ...
Learn why early notified-body engagement is critical for combination products, including design rationale, risk controls, validation evidence and traceable documentation ahead of submission.
Viking Therapeutics, Inc. announced the initiation of an exploratory oral maintenance dosing study of VK2735, the company's (GLP-1) and ...
European Commission approves Nezglyal for rare brain disease On September 21, 2026, the European Commission granted marketing authorization under exceptional circumstances for Nezglyal (leriglitazone) ...
2026年10月2日金曜日 旧暦 2026年8月22日 日の干支 己酉 二十七宿 鬼宿 月の大小 大月（30日） イスラム常用暦 1448-04(Rabia Thani)-19 インド国定暦(サカ暦) 1948-07(Asvina)-10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results